The Oncology Institute, Inc.
TOI
$4.59
$0.122.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.80% | -32.42% | -41.65% | -34.66% | -39.64% |
| Total Receivables | 19.70% | 21.85% | 9.33% | 2.88% | -16.00% |
| Inventory | 97.35% | 68.09% | 86.84% | 39.43% | 6.53% |
| Prepaid Expenses | -44.33% | -25.86% | -11.91% | -33.15% | 9.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.40% | 0.29% | -5.44% | -9.82% | -24.34% |
|
|
|||||
| Total Current Assets | 9.40% | 0.29% | -5.44% | -9.82% | -24.34% |
| Net Property, Plant & Equipment | -5.97% | -12.24% | -13.66% | -11.43% | -8.03% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -26.62% | -25.62% | -24.71% | -23.89% | -18.07% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.91% | 2.89% | -0.34% | 0.69% | 4.05% |
| Total Assets | 2.58% | -4.67% | -8.69% | -11.03% | -19.82% |
|
|
|||||
| Total Accounts Payable | 62.68% | 77.47% | 45.02% | 121.80% | 39.38% |
| Total Accrued Expenses | 110.30% | 22.31% | 27.25% | 38.03% | 3.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.58% | 5.80% | 6.51% | 6.51% | 6.55% |
| Total Finance Division Other Current Liabilities | -55.79% | -24.76% | 72.14% | 113.10% | 46.40% |
| Total Other Current Liabilities | -55.79% | -24.76% | 72.14% | 113.10% | 46.40% |
| Total Current Liabilities | 33.27% | 35.90% | 40.26% | 84.54% | 30.09% |
|
|
|||||
| Total Current Liabilities | 33.27% | 35.90% | 40.26% | 84.54% | 30.09% |
| Long-Term Debt | 6.38% | -16.89% | -16.76% | -16.59% | -16.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.88% | -17.50% | -18.35% | -13.78% | -13.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 99.92% | 2,199.64% | 1,974.52% | 965.52% | -2.19% |
| Total Liabilities | 16.10% | 6.65% | 7.45% | 12.23% | -2.64% |
|
|
|||||
| Common Stock & APIC | 9.37% | 19.17% | 17.99% | 13.08% | 13.50% |
| Retained Earnings | -18.89% | -28.75% | -33.54% | -36.30% | -38.76% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -421.27% | -538.01% | -179.28% | -130.76% | -87.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -421.27% | -538.01% | -179.28% | -130.76% | -87.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -421.27% | -538.01% | -179.28% | -130.76% | -87.73% |
|
|
|||||